Thiruvananthapuram, June 17: A new scientific study by the Rajiv Gandhi Centre for Biotechnology (RGCB) has found that malaria parasites may exploit young blood cells to evade drug action, offering fresh insights into how the disease persists despite treatment.
The study suggests that immature red blood cells provide a more favourable environment for malaria parasites, allowing them to survive and potentially reduce the effectiveness of anti-malarial drugs. This discovery could help explain why certain infections are harder to eliminate in some patients.
Researchers noted that understanding the interaction between malaria parasites and young blood cells is critical for improving treatment strategies and developing more effective therapeutic approaches. The findings may contribute to refining existing drug protocols and guiding future anti-malarial research.
Malaria remains a significant public health challenge in several regions, and drug resistance continues to complicate efforts to control the disease. The new study adds an important dimension to ongoing global research aimed at improving disease management and reducing mortality.
The RGCB team emphasized that further research is needed to explore how this mechanism operates in clinical settings and how it can be targeted for improved treatment outcomes.
The study is expected to support future innovations in malaria therapy and strengthen scientific understanding of parasite survival mechanisms.